Industry Research Reports
Home > Reports > Pharma & Healthcare > Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Intermediates Market Size(US$)
CAGR 2025-2031
6.3%
Market Size,2031
USD 313,420
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 217,230 million
Market Forecast in 2031(Value)
US$ 313,420 million
CAGR
6.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Global Pharmaceutical Intermediates key players include Wartsila, Hyundai, MAN, MES, Caterpillar, etc. Global top three manufacturers hold a share over 45%.
China is the largest production area, with a share about 30%, followed by India and North America, both have a share over 40 percent.
In terms of product, GMP is the largest segment, with a share over 80%. And in terms of application, the largest application is Antibiotics, followed by Antipyretic analgesics, etc.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Intermediates, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Intermediates by region & country, by Type, and by Application.
The Pharmaceutical Intermediates market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Intermediates.
MARKET SEGMENTATION
By Company
- Lonza
- Catalent
- Patheon
- Jubilant
- Granules
- Ganesh
- Chemcon
- BASF
- Porton
- Lianhetech
- ABA Chem
- Tianma
- Jiujiujiu
- Alpha
- Jiuzhou
- Yongtai
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- GMP
- Non-GMP
Segment by Application
- Antibiotics
- Antipyretic Analgesics
- Vitamins
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Intermediates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pharmaceutical Intermediates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pharmaceutical Intermediates in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Intermediates Product Introduction
1.2 Global Pharmaceutical Intermediates Market Size Forecast
1.2.1 Global Pharmaceutical Intermediates Sales Value (2020-2031)
1.2.2 Global Pharmaceutical Intermediates Sales Volume (2020-2031)
1.2.3 Global Pharmaceutical Intermediates Sales Price (2020-2031)
1.3 Pharmaceutical Intermediates Market Trends & Drivers
1.3.1 Pharmaceutical Intermediates Industry Trends
1.3.2 Pharmaceutical Intermediates Market Drivers & Opportunity
1.3.3 Pharmaceutical Intermediates Market Challenges
1.3.4 Pharmaceutical Intermediates Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Intermediates Players Revenue Ranking (2024)
2.2 Global Pharmaceutical Intermediates Revenue by Company (2020-2025)
2.3 Global Pharmaceutical Intermediates Players Sales Volume Ranking (2024)
2.4 Global Pharmaceutical Intermediates Sales Volume by Company Players (2020-2025)
2.5 Global Pharmaceutical Intermediates Average Price by Company (2020-2025)
2.6 Key Manufacturers Pharmaceutical Intermediates Manufacturing Base and Headquarters
2.7 Key Manufacturers Pharmaceutical Intermediates Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pharmaceutical Intermediates
2.9 Pharmaceutical Intermediates Market Competitive Analysis
2.9.1 Pharmaceutical Intermediates Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Intermediates Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 GMP
3.1.2 Non-GMP
3.2 Global Pharmaceutical Intermediates Sales Value by Type
3.2.1 Global Pharmaceutical Intermediates Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pharmaceutical Intermediates Sales Value, by Type (2020-2031)
3.2.3 Global Pharmaceutical Intermediates Sales Value, by Type (%) (2020-2031)
3.3 Global Pharmaceutical Intermediates Sales Volume by Type
3.3.1 Global Pharmaceutical Intermediates Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Pharmaceutical Intermediates Sales Volume, by Type (2020-2031)
3.3.3 Global Pharmaceutical Intermediates Sales Volume, by Type (%) (2020-2031)
3.4 Global Pharmaceutical Intermediates Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Antibiotics
4.1.2 Antipyretic Analgesics
4.1.3 Vitamins
4.1.4 Others
4.2 Global Pharmaceutical Intermediates Sales Value by Application
4.2.1 Global Pharmaceutical Intermediates Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pharmaceutical Intermediates Sales Value, by Application (2020-2031)
4.2.3 Global Pharmaceutical Intermediates Sales Value, by Application (%) (2020-2031)
4.3 Global Pharmaceutical Intermediates Sales Volume by Application
4.3.1 Global Pharmaceutical Intermediates Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Pharmaceutical Intermediates Sales Volume, by Application (2020-2031)
4.3.3 Global Pharmaceutical Intermediates Sales Volume, by Application (%) (2020-2031)
4.4 Global Pharmaceutical Intermediates Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Pharmaceutical Intermediates Sales Value by Region
5.1.1 Global Pharmaceutical Intermediates Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pharmaceutical Intermediates Sales Value by Region (2020-2025)
5.1.3 Global Pharmaceutical Intermediates Sales Value by Region (2026-2031)
5.1.4 Global Pharmaceutical Intermediates Sales Value by Region (%), (2020-2031)
5.2 Global Pharmaceutical Intermediates Sales Volume by Region
5.2.1 Global Pharmaceutical Intermediates Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Pharmaceutical Intermediates Sales Volume by Region (2020-2025)
5.2.3 Global Pharmaceutical Intermediates Sales Volume by Region (2026-2031)
5.2.4 Global Pharmaceutical Intermediates Sales Volume by Region (%), (2020-2031)
5.3 Global Pharmaceutical Intermediates Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Pharmaceutical Intermediates Sales Value, 2020-2031
5.4.2 North America Pharmaceutical Intermediates Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Pharmaceutical Intermediates Sales Value, 2020-2031
5.5.2 Europe Pharmaceutical Intermediates Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Intermediates Sales Value, 2020-2031
5.6.2 Asia Pacific Pharmaceutical Intermediates Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Pharmaceutical Intermediates Sales Value, 2020-2031
5.7.2 South America Pharmaceutical Intermediates Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Intermediates Sales Value, 2020-2031
5.8.2 Middle East & Africa Pharmaceutical Intermediates Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Intermediates Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pharmaceutical Intermediates Sales Value
6.2.1 Key Countries/Regions Pharmaceutical Intermediates Sales Value, 2020-2031
6.2.2 Key Countries/Regions Pharmaceutical Intermediates Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Pharmaceutical Intermediates Sales Value, 2020-2031
6.3.2 United States Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pharmaceutical Intermediates Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pharmaceutical Intermediates Sales Value, 2020-2031
6.4.2 Europe Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pharmaceutical Intermediates Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pharmaceutical Intermediates Sales Value, 2020-2031
6.5.2 China Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pharmaceutical Intermediates Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pharmaceutical Intermediates Sales Value, 2020-2031
6.6.2 Japan Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pharmaceutical Intermediates Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pharmaceutical Intermediates Sales Value, 2020-2031
6.7.2 South Korea Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pharmaceutical Intermediates Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Intermediates Sales Value, 2020-2031
6.8.2 Southeast Asia Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pharmaceutical Intermediates Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pharmaceutical Intermediates Sales Value, 2020-2031
6.9.2 India Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pharmaceutical Intermediates Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Lonza
7.1.1 Lonza Company Information
7.1.2 Lonza Introduction and Business Overview
7.1.3 Lonza Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Lonza Pharmaceutical Intermediates Product Offerings
7.1.5 Lonza Recent Development
7.2 Catalent
7.2.1 Catalent Company Information
7.2.2 Catalent Introduction and Business Overview
7.2.3 Catalent Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Catalent Pharmaceutical Intermediates Product Offerings
7.2.5 Catalent Recent Development
7.3 Patheon
7.3.1 Patheon Company Information
7.3.2 Patheon Introduction and Business Overview
7.3.3 Patheon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Patheon Pharmaceutical Intermediates Product Offerings
7.3.5 Patheon Recent Development
7.4 Jubilant
7.4.1 Jubilant Company Information
7.4.2 Jubilant Introduction and Business Overview
7.4.3 Jubilant Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Jubilant Pharmaceutical Intermediates Product Offerings
7.4.5 Jubilant Recent Development
7.5 Granules
7.5.1 Granules Company Information
7.5.2 Granules Introduction and Business Overview
7.5.3 Granules Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Granules Pharmaceutical Intermediates Product Offerings
7.5.5 Granules Recent Development
7.6 Ganesh
7.6.1 Ganesh Company Information
7.6.2 Ganesh Introduction and Business Overview
7.6.3 Ganesh Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Ganesh Pharmaceutical Intermediates Product Offerings
7.6.5 Ganesh Recent Development
7.7 Chemcon
7.7.1 Chemcon Company Information
7.7.2 Chemcon Introduction and Business Overview
7.7.3 Chemcon Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Chemcon Pharmaceutical Intermediates Product Offerings
7.7.5 Chemcon Recent Development
7.8 BASF
7.8.1 BASF Company Information
7.8.2 BASF Introduction and Business Overview
7.8.3 BASF Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 BASF Pharmaceutical Intermediates Product Offerings
7.8.5 BASF Recent Development
7.9 Porton
7.9.1 Porton Company Information
7.9.2 Porton Introduction and Business Overview
7.9.3 Porton Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Porton Pharmaceutical Intermediates Product Offerings
7.9.5 Porton Recent Development
7.10 Lianhetech
7.10.1 Lianhetech Company Information
7.10.2 Lianhetech Introduction and Business Overview
7.10.3 Lianhetech Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Lianhetech Pharmaceutical Intermediates Product Offerings
7.10.5 Lianhetech Recent Development
7.11 ABA Chem
7.11.1 ABA Chem Company Information
7.11.2 ABA Chem Introduction and Business Overview
7.11.3 ABA Chem Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 ABA Chem Pharmaceutical Intermediates Product Offerings
7.11.5 ABA Chem Recent Development
7.12 Tianma
7.12.1 Tianma Company Information
7.12.2 Tianma Introduction and Business Overview
7.12.3 Tianma Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Tianma Pharmaceutical Intermediates Product Offerings
7.12.5 Tianma Recent Development
7.13 Jiujiujiu
7.13.1 Jiujiujiu Company Information
7.13.2 Jiujiujiu Introduction and Business Overview
7.13.3 Jiujiujiu Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Jiujiujiu Pharmaceutical Intermediates Product Offerings
7.13.5 Jiujiujiu Recent Development
7.14 Alpha
7.14.1 Alpha Company Information
7.14.2 Alpha Introduction and Business Overview
7.14.3 Alpha Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Alpha Pharmaceutical Intermediates Product Offerings
7.14.5 Alpha Recent Development
7.15 Jiuzhou
7.15.1 Jiuzhou Company Information
7.15.2 Jiuzhou Introduction and Business Overview
7.15.3 Jiuzhou Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Jiuzhou Pharmaceutical Intermediates Product Offerings
7.15.5 Jiuzhou Recent Development
7.16 Yongtai
7.16.1 Yongtai Company Information
7.16.2 Yongtai Introduction and Business Overview
7.16.3 Yongtai Pharmaceutical Intermediates Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Yongtai Pharmaceutical Intermediates Product Offerings
7.16.5 Yongtai Recent Development
8 Industry Chain Analysis
8.1 Pharmaceutical Intermediates Industrial Chain
8.2 Pharmaceutical Intermediates Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Intermediates Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Intermediates Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Pharmaceutical Intermediates Market Trends
Table 2. Pharmaceutical Intermediates Market Drivers & Opportunity
Table 3. Pharmaceutical Intermediates Market Challenges
Table 4. Pharmaceutical Intermediates Market Restraints
Table 5. Global Pharmaceutical Intermediates Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Pharmaceutical Intermediates Revenue Market Share by Company (2020-2025)
Table 7. Global Pharmaceutical Intermediates Sales Volume by Company (2020-2025) & (K MT)
Table 8. Global Pharmaceutical Intermediates Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Pharmaceutical Intermediates Price by Company (2020-2025) & (USD/MT)
Table 10. Key Manufacturers Pharmaceutical Intermediates Manufacturing Base and Headquarters
Table 11. Key Manufacturers Pharmaceutical Intermediates Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Pharmaceutical Intermediates
Table 13. Global Pharmaceutical Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Intermediates as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Intermediates Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Pharmaceutical Intermediates Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Pharmaceutical Intermediates Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Pharmaceutical Intermediates Sales Market Share in Value by Type (2020-2025)
Table 20. Global Pharmaceutical Intermediates Sales Market Share in Value by Type (2026-2031)
Table 21. Global Pharmaceutical Intermediates Sales Volume by Type: 2020 VS 2024 VS 2031 (K MT)
Table 22. Global Pharmaceutical Intermediates Sales Volume by Type (2020-2025) & (K MT)
Table 23. Global Pharmaceutical Intermediates Sales Volume by Type (2026-2031) & (K MT)
Table 24. Global Pharmaceutical Intermediates Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Pharmaceutical Intermediates Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Pharmaceutical Intermediates Price by Type (2020-2025) & (USD/MT)
Table 27. Global Pharmaceutical Intermediates Price by Type (2026-2031) & (USD/MT)
Table 28. Global Pharmaceutical Intermediates Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Pharmaceutical Intermediates Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Pharmaceutical Intermediates Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Pharmaceutical Intermediates Sales Market Share in Value by Application (2020-2025)
Table 32. Global Pharmaceutical Intermediates Sales Market Share in Value by Application (2026-2031)
Table 33. Global Pharmaceutical Intermediates Sales Volume by Application: 2020 VS 2024 VS 2031 (K MT)
Table 34. Global Pharmaceutical Intermediates Sales Volume by Application (2020-2025) & (K MT)
Table 35. Global Pharmaceutical Intermediates Sales Volume by Application (2026-2031) & (K MT)
Table 36. Global Pharmaceutical Intermediates Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Pharmaceutical Intermediates Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Pharmaceutical Intermediates Price by Application (2020-2025) & (USD/MT)
Table 39. Global Pharmaceutical Intermediates Price by Application (2026-2031) & (USD/MT)
Table 40. Global Pharmaceutical Intermediates Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Pharmaceutical Intermediates Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Pharmaceutical Intermediates Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Pharmaceutical Intermediates Sales Value by Region (2020-2025) & (%)
Table 44. Global Pharmaceutical Intermediates Sales Value by Region (2026-2031) & (%)
Table 45. Global Pharmaceutical Intermediates Sales Volume by Region (K MT): 2020 VS 2024 VS 2031
Table 46. Global Pharmaceutical Intermediates Sales Volume by Region (2020-2025) & (K MT)
Table 47. Global Pharmaceutical Intermediates Sales Volume by Region (2026-2031) & (K MT)
Table 48. Global Pharmaceutical Intermediates Sales Volume by Region (2020-2025) & (%)
Table 49. Global Pharmaceutical Intermediates Sales Volume by Region (2026-2031) & (%)
Table 50. Global Pharmaceutical Intermediates Average Price by Region (2020-2025) & (USD/MT)
Table 51. Global Pharmaceutical Intermediates Average Price by Region (2026-2031) & (USD/MT)
Table 52. Key Countries/Regions Pharmaceutical Intermediates Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Pharmaceutical Intermediates Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Pharmaceutical Intermediates Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Pharmaceutical Intermediates Sales Volume, (2020-2025) & (K MT)
Table 56. Key Countries/Regions Pharmaceutical Intermediates Sales Volume, (2026-2031) & (K MT)
Table 57. Lonza Company Information
Table 58. Lonza Introduction and Business Overview
Table 59. Lonza Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Lonza Pharmaceutical Intermediates Product Offerings
Table 61. Lonza Recent Development
Table 62. Catalent Company Information
Table 63. Catalent Introduction and Business Overview
Table 64. Catalent Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 65. Catalent Pharmaceutical Intermediates Product Offerings
Table 66. Catalent Recent Development
Table 67. Patheon Company Information
Table 68. Patheon Introduction and Business Overview
Table 69. Patheon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Patheon Pharmaceutical Intermediates Product Offerings
Table 71. Patheon Recent Development
Table 72. Jubilant Company Information
Table 73. Jubilant Introduction and Business Overview
Table 74. Jubilant Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Jubilant Pharmaceutical Intermediates Product Offerings
Table 76. Jubilant Recent Development
Table 77. Granules Company Information
Table 78. Granules Introduction and Business Overview
Table 79. Granules Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Granules Pharmaceutical Intermediates Product Offerings
Table 81. Granules Recent Development
Table 82. Ganesh Company Information
Table 83. Ganesh Introduction and Business Overview
Table 84. Ganesh Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Ganesh Pharmaceutical Intermediates Product Offerings
Table 86. Ganesh Recent Development
Table 87. Chemcon Company Information
Table 88. Chemcon Introduction and Business Overview
Table 89. Chemcon Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Chemcon Pharmaceutical Intermediates Product Offerings
Table 91. Chemcon Recent Development
Table 92. BASF Company Information
Table 93. BASF Introduction and Business Overview
Table 94. BASF Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. BASF Pharmaceutical Intermediates Product Offerings
Table 96. BASF Recent Development
Table 97. Porton Company Information
Table 98. Porton Introduction and Business Overview
Table 99. Porton Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Porton Pharmaceutical Intermediates Product Offerings
Table 101. Porton Recent Development
Table 102. Lianhetech Company Information
Table 103. Lianhetech Introduction and Business Overview
Table 104. Lianhetech Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Lianhetech Pharmaceutical Intermediates Product Offerings
Table 106. Lianhetech Recent Development
Table 107. ABA Chem Company Information
Table 108. ABA Chem Introduction and Business Overview
Table 109. ABA Chem Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. ABA Chem Pharmaceutical Intermediates Product Offerings
Table 111. ABA Chem Recent Development
Table 112. Tianma Company Information
Table 113. Tianma Introduction and Business Overview
Table 114. Tianma Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Tianma Pharmaceutical Intermediates Product Offerings
Table 116. Tianma Recent Development
Table 117. Jiujiujiu Company Information
Table 118. Jiujiujiu Introduction and Business Overview
Table 119. Jiujiujiu Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Jiujiujiu Pharmaceutical Intermediates Product Offerings
Table 121. Jiujiujiu Recent Development
Table 122. Alpha Company Information
Table 123. Alpha Introduction and Business Overview
Table 124. Alpha Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Alpha Pharmaceutical Intermediates Product Offerings
Table 126. Alpha Recent Development
Table 127. Jiuzhou Company Information
Table 128. Jiuzhou Introduction and Business Overview
Table 129. Jiuzhou Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 130. Jiuzhou Pharmaceutical Intermediates Product Offerings
Table 131. Jiuzhou Recent Development
Table 132. Yongtai Company Information
Table 133. Yongtai Introduction and Business Overview
Table 134. Yongtai Pharmaceutical Intermediates Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 135. Yongtai Pharmaceutical Intermediates Product Offerings
Table 136. Yongtai Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Pharmaceutical Intermediates Downstream Customers
Table 140. Pharmaceutical Intermediates Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Intermediates Product Picture
Figure 2. Global Pharmaceutical Intermediates Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Pharmaceutical Intermediates Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Pharmaceutical Intermediates Sales Volume (2020-2031) & (K MT)
Figure 5. Global Pharmaceutical Intermediates Sales Price (2020-2031) & (USD/MT)
Figure 6. Pharmaceutical Intermediates Report Years Considered
Figure 7. Global Pharmaceutical Intermediates Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Pharmaceutical Intermediates Players Sales Volume Ranking (2024) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Intermediates Revenue in 2024
Figure 10. Pharmaceutical Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. GMP Picture
Figure 12. Non-GMP Picture
Figure 13. Global Pharmaceutical Intermediates Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Pharmaceutical Intermediates Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Pharmaceutical Intermediates Sales Volume by Type (2020 VS 2024 VS 2031) & (K MT)
Figure 16. Global Pharmaceutical Intermediates Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Pharmaceutical Intermediates Price by Type (2020-2031) & (USD/MT)
Figure 18. Product Picture of Antibiotics
Figure 19. Product Picture of Antipyretic Analgesics
Figure 20. Product Picture of Vitamins
Figure 21. Product Picture of Others
Figure 22. Global Pharmaceutical Intermediates Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Pharmaceutical Intermediates Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Pharmaceutical Intermediates Sales Volume by Application (2020 VS 2024 VS 2031) & (K MT)
Figure 25. Global Pharmaceutical Intermediates Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Pharmaceutical Intermediates Price by Application (2020-2031) & (USD/MT)
Figure 27. North America Pharmaceutical Intermediates Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Pharmaceutical Intermediates Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Pharmaceutical Intermediates Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Pharmaceutical Intermediates Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Pharmaceutical Intermediates Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Pharmaceutical Intermediates Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Pharmaceutical Intermediates Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Pharmaceutical Intermediates Sales Volume (%), (2020-2031)
Figure 39. United States Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Pharmaceutical Intermediates Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Pharmaceutical Intermediates Sales Value by Application (%), 2024 VS 2031
Figure 45. China Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
Figure 47. China Pharmaceutical Intermediates Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Pharmaceutical Intermediates Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Pharmaceutical Intermediates Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Pharmaceutical Intermediates Sales Value by Application (%), 2024 VS 2031
Figure 57. India Pharmaceutical Intermediates Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Pharmaceutical Intermediates Sales Value by Type (%), 2024 VS 2031
Figure 59. India Pharmaceutical Intermediates Sales Value by Application (%), 2024 VS 2031
Figure 60. Pharmaceutical Intermediates Industrial Chain
Figure 61. Pharmaceutical Intermediates Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Pharmaceutical Intermediates in 2031?
The global market size of Pharmaceutical Intermediates in 2031 was 313420 Million USD.
Which companies rank high in the global Pharmaceutical Intermediates market?
What was the global market size of Pharmaceutical Intermediates in 2025?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Pharmaceutical Intermediates market size from 2025 to 2031?
Related Reports
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-16
Pages: 173
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-17
Pages: 177
USD 5600.00
(Single User License)
Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published Date: 2024-04-07
Pages: 117
USD 4900.00
(Single User License)
Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-01-16
Pages: 99
USD 2900.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 178
USD 5900.00
(Single User License)
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Intermediates market size was US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 108
USD 4250.00
(Single User License)
Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 172
USD 4900.00
(Single User License)
Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 147
USD 3950.00
(Single User License)
Global Pharmaceutical Intermediates Market Research Report 2026
The global Pharmaceutical Intermediates market was valued at US$ 217230 million in 2025 and is anticipated to reach US$ 331190 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 136
USD 2900.00
(Single User License)
Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 107
USD 4250.00
(Single User License)
Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-16
Pages: 173
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-17
Pages: 177
USD 5600.00 (Single User License)Global Pharmaceutical Intermediates Market Insights, Forecast to 2030
Pharmaceutical intermediates are chemical material or chemical products, which could be applied in production of active pharmaceutical ingredients. Their production needs not production certification and they can be produced in ordinary chemical factory. There are many kinds of pharmaceutical intermediates, such as cephalosporin intermediates, vitamin intermediates, quinolones intermediates, steroid intermediates, etc.
Published: 2024-04-07
Pages: 117
USD 4900.00 (Single User License)Global Pharmaceutical Intermediates Market Research Report 2025
The global market for Pharmaceutical Intermediates was valued at US$ 205580 million in the year 2024 and is projected to reach a revised size of US$ 313420 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-01-16
Pages: 99
USD 2900.00 (Single User License)Global Pharmaceutical Intermediates Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Pharmaceutical Intermediates was estimated to be worth US$ 205580 million and is forecast to reach approximately US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 178
USD 5900.00 (Single User License)Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Intermediates market size was US$ 205580 million in 2024 and is forecast to a readjusted size of US$ 313420 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 108
USD 4250.00 (Single User License)Global Pharmaceutical Intermediates Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Intermediates market is projected to grow from US$ 205580 million in 2024 to US$ 313420 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 172
USD 4900.00 (Single User License)Pharmaceutical Intermediates- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Intermediates was estimated to be worth US$ 217230 million in 2025 and is projected to reach US$ 331190 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 147
USD 3950.00 (Single User License)Global Pharmaceutical Intermediates Market Research Report 2026
The global Pharmaceutical Intermediates market was valued at US$ 217230 million in 2025 and is anticipated to reach US$ 331190 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 136
USD 2900.00 (Single User License)Global Pharmaceutical Intermediates Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Intermediates market size was US$ 217230 million in 2025 and is forecast to reach a readjusted size of US$ 331190 million by 2032 with a CAGR of 6.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 107
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report